Aphea.Bio

Foundation date

05/12/2016

Sector

#Biotechnology - other

Subsector

Aphea.Bio will develop sustainable agricultural products based on natural microorganisms to increase crop yields and to protect them against specific fungal diseases. Thanks to a successful Series A financing round and an R&D grant approved by Flanders Innovation & Entrepreneurship (VLAIO), Aphea.Bio is now backed by 9 million euros of funding, giving it a clear shot at a leading position in the fast-emerging market of biopesticides and biostimulants. 

Latest news

  • Waste2Func Video Release: The technology is ready, are we?

    Friday May 24th 2024

  • BIO INX and Readily3D Announce Collaboration to Advance Volumetric Bioprinting with Cutting-edge Gel-MA Based Ink

    Wednesday May 22nd 2024

  • Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®

    Wednesday May 22nd 2024